Table 4 Numbers of genes differentially expressed relative to UKF-NB-3 (false discovery rate (FDR)<0.05 or <0.01 after correction for multiple testing) in RITA- or nutlin-3-adapted UKF-NB-3 sub-lines as determined by microarray measurement of mRNA abundance

From: Human neuroblastoma cells with acquired resistance to the p53 activator RITA retain functional p53 and sensitivity to other p53 activating agents